Detalles de la búsqueda
1.
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells.
Cancer Immunol Immunother
; 67(10): 1519-1531, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30039427
2.
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.
Cytotherapy
; 20(7): 952-963, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30180944
3.
CAR T cells: driving the road from the laboratory to the clinic.
Immunol Rev
; 257(1): 91-106, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24329792
4.
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity.
Cancer Immunol Immunother
; 66(11): 1425-1436, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28660319
5.
Exploiting natural killer group 2D receptors for CAR T-cell therapy.
Future Oncol
; 13(18): 1593-1605, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28613086
6.
Differential role of Th1 and Th2 cytokines in autotoxicity driven by CD19-specific second-generation chimeric antigen receptor T cells in a mouse model.
J Immunol
; 192(8): 3654-65, 2014 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24623129
7.
Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial.
Cancer Immunol Immunother
; 63(2): 133-45, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24190544
8.
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.
Haematologica
; 103(9): e424-e426, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703727
9.
Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignancies.
EJHaem
; 4(3): 882-885, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601889
10.
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
Lancet Haematol
; 10(3): e191-e202, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36764323
11.
Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?
Breast Cancer Res
; 14(3): 106, 2012 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22643384
12.
Targeted immunotherapy of cancer with CAR T cells: achievements and challenges.
Cancer Immunol Immunother
; 61(7): 953-62, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22527245
13.
Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy.
Cancer Immunol Immunother
; 61(7): 1005-18, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22127365
14.
The optimal antigen response of chimeric antigen receptors harboring the CD3zeta transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 complex.
J Immunol
; 184(12): 6938-49, 2010 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20483753
15.
Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T cells.
J Immunol
; 184(4): 1885-96, 2010 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20089697
16.
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non-Gene-edited Allogeneic CAR T-Cell Therapy.
J Immunother
; 45(3): 150-161, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35191428
17.
Gene delivery of a mutant TGFß3 reduces markers of scar tissue formation after cutaneous wounding.
Mol Ther
; 18(12): 2104-11, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20736928
18.
Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectors.
J Gene Med
; 12(2): 129-36, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20033928
19.
Development of a flow cytometric co-immunoprecipitation technique for the study of multiple protein-protein interactions and its application to T-cell receptor analysis.
Cytometry A
; 77(4): 338-46, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20033991
20.
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.
JCI Insight
; 5(19)2020 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33004686